Intellicell Biosciences Inc (fka SVFC)

[Traderboy1966]

Dr. Harry Fisch has joined the Board of Scientific Advisors and will head up the new Urology Department at IntelliCell.

IntelliCell's Chairman and CEO, Dr. Steven Victor stated, "Our Company is very pleased to announce today that Dr. Fisch is joining our Advisory Board and will be the Director of Urology for IntelliCell. He is a pioneering surgeon and respected on the national stage for his work on microsurgical techniques. I am looking forward to working with him as we expand the potential benefits of Regenerative Medicine into the practice of urology."

Said Dr. Fisch, "I believe that the promise of Regenerative Medicine for patients suffering from a number of urological disorders including erectile dysfunction may become an important part in the practice of medicine. This is an exciting time in medicine and I am looking forward to working with cutting edge technologies like IntelliCell's and improving the clinical outcomes of my patients."



Dr. Harry Fisch is a board certified urologist at New York Presbyterian Hospital/Weill Medical College of Cornell University. He is one of the nation's leaders in the diagnosis and treatment of Men's health issues as well as sexuality and fertility problems in couples. Internationally renowned, he has pioneered microsurgical techniques for disorders associated with male infertility such as vasectomy reversal and varicocele repair. He has been named to the “Best Doctors in America" and "New York Magazine Top Doctor" the past 9 years. He regularly appears on the Dr. Oz show as a medical expert on Men's Health.

For over fifteen years, Dr. Fisch has focused his research, practice, and surgery on male infertility and reproduction. His recent article describes a new microsurgical technique for varicocelectomy. In his private practice in Manhattan, Dr. Fisch has successfully treated thousands of men with sexuality and fertility problems. Dr. Fisch's research on sperm counts and endocrine disrupters has resulted in multiple research articles and international attention. His work has been frequently cited in a variety of publications, including USA Today, The New York Times, and The Washington Post. He has appeared on television's 60 Minutes, 20/20, CNN and Today, among many others.